• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 8-K filed by Olaplex Holdings Inc.

    7/11/24 8:31:31 AM ET
    $OLPX
    Package Goods/Cosmetics
    Consumer Discretionary
    Get the next $OLPX alert in real time by email
    8-K
    false 0001868726 0001868726 2024-07-11 2024-07-11

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, DC 20549

     

     

    FORM 8-K

     

     

    CURRENT REPORT

    Pursuant to Section 13 or 15(d)

    of the Securities Exchange Act of 1934

    Date of report (Date of earliest event reported): July 11, 2024

     

     

    Olaplex Holdings, Inc.

    (Exact name of registrant as specified in its charter)

     

     

     

    Delaware   001-40860   87-1242679

    (State or other jurisdiction

    of incorporation)

     

    (Commission

    File Number)

     

    (IRS Employer

    Identification No.)

    432 Park Avenue South, Third Floor

    New York, NY 10016

    (Address of principal executive offices) (Zip Code)

    Registrant’s telephone number, including area code: (310) 691-0776

    Not applicable

    (Former name or former address, if changed since last report.)

     

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

    ☐

    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

     

    ☐

    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

     

    ☐

    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

     

    ☐

    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class

     

    Trading

    Symbol

     

    Name of each exchange

    on which registered

    Common Stock, par value $0.001 per share   OLPX   Nasdaq Global Select Market

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

    Emerging growth company ☐

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     

     

     


    Item 5.02   Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

    On July 11, 2024, Olaplex Holdings, Inc. (the “Company”) announced that the Company intends to appoint Catherine Dunleavy, age 55, as Chief Operating Officer (“COO”) and Chief Financial Officer (“CFO”) of the Company, effective as of August 13, 2024.

    The Company has entered into a letter agreement (the “Offer Letter”) with Ms. Dunleavy, pursuant to which Ms. Dunleavy and the Company have agreed that she will join the Company as COO and CFO, effective as of August 13, 2024, at which time she will succeed Paul Kosturos, who has served as interim Chief Financial Officer since May 6, 2024.

    Ms. Dunleavy served as President of the travel lifestyle brand Away from November 2022 until May 2024 and as Chief Financial Officer from October 2020 until November 2022. Prior to joining Away, Ms. Dunleavy spent three years at Nike, from April 2017 until October 2020, serving as Divisional Chief Financial Officer. Prior to joining Nike, she spent 16 years at Comcast and NBCUniversal, where she served in numerous roles, including Chief Financial Officer of the Cable Entertainment Group and Executive Vice President, Content Distribution. She began her career at General Electric.

    The Offer Letter provides for (i) an annual base salary of $675,000; (ii) an annual bonus opportunity with a target of 50% of her annual base salary and with the actual amount of such bonus based upon achievement of certain individual and Company performance goals; and (iii) reimbursement of up to $10,000 for legal fees incurred in the negotiation of the Offer Letter and related documentation.

    The Offer Letter provides that Ms. Dunleavy will be granted two new hire equity grants consisting of restricted stock unit awards with values approximately equal to $1,500,000 and $500,000, respectively, on the grant date based on the closing price of a share of the Company’s common stock, par value $0.001 per share (“Common Stock”) on the grant date (the “New Hire RSU Awards”). The New Hire RSU Awards will vest as to twenty-five percent (25%) on each of the first four (4) anniversaries of the grant date, and, solely with respect to the $500,000 grant as referenced above, as to one-hundred percent (100%) in the event of a change in control of the Company (as defined in the applicable award agreement), in each case, subject to Ms. Dunleavy’s continued employment through the applicable vesting date. Beginning in 2025, Ms. Dunleavy will be eligible for annual equity awards of the Company with a target aggregate grant date value of not less than $1,500,000, subject to the approval of the Company’s board of directors (the “Board”) (or the compensation committee of the Board).

    As a condition to the grant of the New Hire RSU Awards, Ms. Dunleavy must sign a restrictive covenant agreement providing for perpetual confidentiality and assignment of intellectual property obligations and non-competition and non-solicitation obligations during Ms. Dunleavy’s employment and for a period of twenty-four (24) months following termination of her employment.

    The Offer Letter also provides that if Ms. Dunleavy’s employment is terminated by the Company without cause or if Ms. Dunleavy terminates her employment with the Company for good reason (as such terms are defined in the Offer Letter), she will be entitled to receive (i) continued payment of her base salary for twelve (12) months following her termination of employment; (ii) a COBRA subsidy for the same time period; and (iii) payment of any earned but unpaid prior year annual bonus, paid when annual bonuses are paid to senior executives of the Company generally (the “Prior Year’s Bonus”). The severance benefits are subject to Ms. Dunleavy’s execution of a separation agreement and general release of claims in favor of the Company and her continued compliance with her restrictive covenant obligations.


    If Ms. Dunleavy’s employment is terminated due to her death or disability, she will be entitled to receive the Prior Year’s Bonus.

    Ms. Dunleavy and the Company will enter into an indemnification agreement in substantially similar form as Exhibit 10.2 to the Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission (the “SEC”) on February 29, 2024.

    This Current Report on Form 8-K contains forward-looking statements. Investors are cautioned not to place undue reliance on these forward-looking statements, including statements about the anticipated leadership transition, including the expected date thereof. Each forward-looking statement is subject to risks and uncertainties that could cause actual events to differ materially from those expressed or implied in such statement. Applicable risks and uncertainties include those related to the possibility that the leadership transition does not occur as anticipated for any reason or on the expected timing and the risks listed under the heading “Risk Factors” and elsewhere in the Company’s Annual Report on Form 10-K filed with the SEC on February 29, 2024, and in the Company’s subsequent SEC filings. These forward-looking statements speak only as of the date of this Current Report on Form 8-K, and the Company undertakes no obligation to update these forward-looking statements.


    Signatures

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed by the undersigned hereunto duly authorized.

     

    Date: July 11, 2024   Olaplex Holdings, Inc.
        By:  

    /s/ Amanda Baldwin

        Name:   Amanda Baldwin
        Title:   Chief Executive Officer
    Get the next $OLPX alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $OLPX

    DatePrice TargetRatingAnalyst
    1/14/2026$1.50Hold
    Jefferies
    11/20/2025$2.00Outperform
    Northland Capital
    8/25/2025$2.00Hold → Buy
    Canaccord Genuity
    8/7/2024$2.00 → $3.00Market Perform
    Telsey Advisory Group
    3/19/2024$1.25 → $2.00Underweight → Neutral
    Piper Sandler
    10/4/2023Underweight → Equal Weight
    Barclays
    8/25/2023$3.00 → $2.00Neutral → Underweight
    Piper Sandler
    8/11/2023$5.00 → $3.00Buy → Hold
    Canaccord Genuity
    More analyst ratings

    $OLPX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Olaplex Holdings, Inc. to Report Third Quarter Fiscal 2025 Financial Results on November 6th

    NEW YORK, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Olaplex Holdings, Inc. ("OLAPLEX"), today announced that it plans to report third quarter fiscal 2025 financial results before the market opens on Thursday, November 6, 2025. The company plans to host an investor conference call and webcast to review third quarter fiscal 2025 financial results at 9:00am ET/6:00am PT on the same day. The webcast can be accessed at https://ir.olaplex.com/. The conference call can be accessed by calling (201) 689-8521 or (877) 407-8813 for a toll-free number. A replay of the webcast will remain available on the website for 90 days. About OLAPLEX OLAPLEX is a foundational health and beauty company powered by breakt

    10/23/25 6:45:00 AM ET
    $OLPX
    Package Goods/Cosmetics
    Consumer Discretionary

    Olaplex Holdings, Inc. Announces Participation in the Barclays 18th Annual Global Consumer Staples Conference on September 2nd

    NEW YORK, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Olaplex Holdings, Inc. ("OLAPLEX"), today announced its participation in the Barclays 18th Annual Global Consumer Staples Conference in Boston, MA. Amanda Baldwin, Chief Executive Officer, and Catherine Dunleavy, Chief Operating Officer & Chief Financial Officer, will present on Tuesday, September 2, 2025 at 3:45pm ET and hold meetings with investors throughout the day. The audio portion of the fireside chat will be available on the Company's Investor Relations website, https://ir.olaplex.com/, and will remain there for 90 days following the event. About OLAPLEX OLAPLEX is a foundational health and beauty company powered by breakthrough innovat

    8/27/25 4:05:00 PM ET
    $OLPX
    Package Goods/Cosmetics
    Consumer Discretionary

    OLAPLEX Acquires Biotech Company Purvala

    NEW YORK, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Olaplex Holdings, Inc. (NASDAQ:OLPX) ("OLAPLEX" or the "Company") today announced the acquisition of Purvala Bioscience, a Boston-based biotech company. This marks the first acquisition from OLAPLEX since the brand launched over ten years ago with breakthrough product formulations and a new-to-market philosophy around bond-building in haircare. Purvala is a Boston-based company founded by Drs. Bradley Olsen, Justin Paloni, and colleagues that seeks to develop transformative bioinspired technologies with applications across health and beauty industries. Since its launch in 2020, Purvala has focused on the creation of high-performing molecules i

    8/26/25 6:55:00 AM ET
    $OLPX
    Package Goods/Cosmetics
    Consumer Discretionary

    $OLPX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Jefferies resumed coverage on Olaplex with a new price target

    Jefferies resumed coverage of Olaplex with a rating of Hold and set a new price target of $1.50

    1/14/26 8:43:59 AM ET
    $OLPX
    Package Goods/Cosmetics
    Consumer Discretionary

    Northland Capital initiated coverage on Olaplex with a new price target

    Northland Capital initiated coverage of Olaplex with a rating of Outperform and set a new price target of $2.00

    11/20/25 9:42:07 AM ET
    $OLPX
    Package Goods/Cosmetics
    Consumer Discretionary

    Olaplex upgraded by Canaccord Genuity with a new price target

    Canaccord Genuity upgraded Olaplex from Hold to Buy and set a new price target of $2.00

    8/25/25 8:08:37 AM ET
    $OLPX
    Package Goods/Cosmetics
    Consumer Discretionary

    $OLPX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Baldwin Amanda sold $474,286 worth of shares (398,560 units at $1.19), decreasing direct ownership by 6% to 5,735,198 units (SEC Form 4)

    4 - OLAPLEX HOLDINGS, INC. (0001868726) (Issuer)

    12/15/25 4:08:33 PM ET
    $OLPX
    Package Goods/Cosmetics
    Consumer Discretionary

    Director Glynn Tricia was granted 110,294 shares, increasing direct ownership by 80% to 248,693 units (SEC Form 4)

    4 - OLAPLEX HOLDINGS, INC. (0001868726) (Issuer)

    8/15/25 9:42:25 PM ET
    $OLPX
    Package Goods/Cosmetics
    Consumer Discretionary

    Director White Michael James was granted 110,294 shares, increasing direct ownership by 80% to 248,693 units (SEC Form 4)

    4 - OLAPLEX HOLDINGS, INC. (0001868726) (Issuer)

    8/15/25 9:41:18 PM ET
    $OLPX
    Package Goods/Cosmetics
    Consumer Discretionary

    $OLPX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Officer Egan Kenneth F bought $13,400 worth of shares (10,000 units at $1.34) (SEC Form 4)

    4 - OLAPLEX HOLDINGS, INC. (0001868726) (Issuer)

    3/18/25 4:03:21 PM ET
    $OLPX
    Package Goods/Cosmetics
    Consumer Discretionary

    Director Bilbrey John P bought $134,695 worth of shares (76,825 units at $1.75) (SEC Form 4)

    4 - OLAPLEX HOLDINGS, INC. (0001868726) (Issuer)

    11/19/24 4:04:17 PM ET
    $OLPX
    Package Goods/Cosmetics
    Consumer Discretionary

    Chief Executive Officer Baldwin Amanda bought $74,390 worth of shares (43,000 units at $1.73), increasing direct ownership by 1% to 3,205,055 units (SEC Form 4)

    4 - OLAPLEX HOLDINGS, INC. (0001868726) (Issuer)

    11/12/24 4:19:40 PM ET
    $OLPX
    Package Goods/Cosmetics
    Consumer Discretionary

    $OLPX
    SEC Filings

    View All

    SEC Form 10-Q filed by Olaplex Holdings Inc.

    10-Q - OLAPLEX HOLDINGS, INC. (0001868726) (Filer)

    11/6/25 4:03:24 PM ET
    $OLPX
    Package Goods/Cosmetics
    Consumer Discretionary

    Olaplex Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - OLAPLEX HOLDINGS, INC. (0001868726) (Filer)

    11/6/25 6:46:53 AM ET
    $OLPX
    Package Goods/Cosmetics
    Consumer Discretionary

    Olaplex Holdings Inc. filed SEC Form 8-K: Regulation FD Disclosure

    8-K - OLAPLEX HOLDINGS, INC. (0001868726) (Filer)

    8/26/25 6:55:13 AM ET
    $OLPX
    Package Goods/Cosmetics
    Consumer Discretionary

    $OLPX
    Leadership Updates

    Live Leadership Updates

    View All

    OLAPLEX Expands Board of Directors with Strategic Appointments

    NEW YORK, July 23, 2025 (GLOBE NEWSWIRE) -- Olaplex Holdings, Inc. (NASDAQ:OLPX) ("OLAPLEX" or the "Company") appointed Jerome Griffith to the Company's Board of Directors (the "Board"), effective July 20, 2025, joining Pamela Edwards, who was appointed to the Board effective March 20, 2025. Ms. Edwards is a highly experienced financial leader, having served as a Chief Financial Officer for several large specialty retailers and consumer brands. Most recently, Ms. Edwards served as the Chief Financial Officer and Executive Vice President of Citi Trends, Inc., a publicly held, leading specialty value store with a rich history of bringing fashionable products across categories from fashion a

    7/23/25 6:45:00 AM ET
    $OLPX
    Package Goods/Cosmetics
    Consumer Discretionary

    OLAPLEX Strengthens Senior Leadership Team with Key Appointments

    NEW YORK, July 11, 2024 (GLOBE NEWSWIRE) -- Olaplex Holdings, Inc. (NASDAQ:OLPX) ("OLAPLEX" or "the Company") today announced the appointment of two highly seasoned leaders to its executive team. Catherine Dunleavy will join OLAPLEX as Chief Operating Officer and Chief Financial Officer, effective August 13, and Katie Gohman will join the Company as Chief Marketing Officer, effective July 15. Ms. Dunleavy brings more than two decades of experience driving the strategy and performance of premier consumer brands. Most recently, she served as President, and, prior to that, as Chief Financial Officer at Away, following tenures at Nike, Comcast, NBCUniversal, and GE. In her new role, she will

    7/11/24 8:00:40 AM ET
    $OLPX
    $TGNA
    Package Goods/Cosmetics
    Consumer Discretionary
    Broadcasting
    Industrials

    OLAPLEX Appoints Global Consumer Industry Veteran John P. Bilbrey to Board of Directors

    SANTA BARBARA, Calif., July 11, 2023 (GLOBE NEWSWIRE) -- Olaplex Holdings, Inc. (NASDAQ:OLPX) ("OLAPLEX" or the "Company"), today announced that it has appointed John P. "JP" Bilbrey to the Company's Board of Directors (the "Board"). A seasoned and accomplished executive within the global consumer space, Mr. Bilbrey will serve in the newly created role of Executive Chair of the Board. Christine Dagousset, who has been a board member of the Company and its predecessor entities since May 2020 and has served as Chair of the Board since August 2021, will continue to serve as a valued director and will transition from a member of the Compensation Committee to a member of the Nominating and Corp

    7/11/23 8:00:47 AM ET
    $OLPX
    Package Goods/Cosmetics
    Consumer Discretionary

    $OLPX
    Financials

    Live finance-specific insights

    View All

    Olaplex Holdings, Inc. to Report Third Quarter Fiscal 2025 Financial Results on November 6th

    NEW YORK, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Olaplex Holdings, Inc. ("OLAPLEX"), today announced that it plans to report third quarter fiscal 2025 financial results before the market opens on Thursday, November 6, 2025. The company plans to host an investor conference call and webcast to review third quarter fiscal 2025 financial results at 9:00am ET/6:00am PT on the same day. The webcast can be accessed at https://ir.olaplex.com/. The conference call can be accessed by calling (201) 689-8521 or (877) 407-8813 for a toll-free number. A replay of the webcast will remain available on the website for 90 days. About OLAPLEX OLAPLEX is a foundational health and beauty company powered by breakt

    10/23/25 6:45:00 AM ET
    $OLPX
    Package Goods/Cosmetics
    Consumer Discretionary

    OLAPLEX Acquires Biotech Company Purvala

    NEW YORK, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Olaplex Holdings, Inc. (NASDAQ:OLPX) ("OLAPLEX" or the "Company") today announced the acquisition of Purvala Bioscience, a Boston-based biotech company. This marks the first acquisition from OLAPLEX since the brand launched over ten years ago with breakthrough product formulations and a new-to-market philosophy around bond-building in haircare. Purvala is a Boston-based company founded by Drs. Bradley Olsen, Justin Paloni, and colleagues that seeks to develop transformative bioinspired technologies with applications across health and beauty industries. Since its launch in 2020, Purvala has focused on the creation of high-performing molecules i

    8/26/25 6:55:00 AM ET
    $OLPX
    Package Goods/Cosmetics
    Consumer Discretionary

    Olaplex Holdings, Inc. to Report Second Quarter Fiscal 2025 Financial Results on August 7th

    NEW YORK, July 24, 2025 (GLOBE NEWSWIRE) -- Olaplex Holdings, Inc. ("OLAPLEX"), today announced that it plans to report second quarter fiscal 2025 financial results before the market opens on Thursday, August 7, 2025. The company plans to host an investor conference call and webcast to review second quarter fiscal 2025 financial results at 9:00am ET/6:00am PT on the same day. The webcast can be accessed at https://ir.olaplex.com/. The conference call can be accessed by calling (201) 689-8521 or (877) 407-8813 for a toll-free number. A replay of the webcast will remain available on the website for 90 days. About OLAPLEX OLAPLEX is a foundational health and beauty company powered by br

    7/24/25 6:45:00 AM ET
    $OLPX
    Package Goods/Cosmetics
    Consumer Discretionary

    $OLPX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Olaplex Holdings Inc. (Amendment)

    SC 13G/A - OLAPLEX HOLDINGS, INC. (0001868726) (Subject)

    2/14/24 4:00:32 PM ET
    $OLPX
    Package Goods/Cosmetics
    Consumer Discretionary

    SEC Form SC 13G/A filed by Olaplex Holdings Inc. (Amendment)

    SC 13G/A - OLAPLEX HOLDINGS, INC. (0001868726) (Subject)

    2/9/24 9:28:33 AM ET
    $OLPX
    Package Goods/Cosmetics
    Consumer Discretionary

    SEC Form SC 13G filed by Olaplex Holdings Inc.

    SC 13G - OLAPLEX HOLDINGS, INC. (0001868726) (Subject)

    2/9/23 12:01:00 PM ET
    $OLPX
    Package Goods/Cosmetics
    Consumer Discretionary